Home/Filings/4/0001209191-23-022777
4//SEC Filing

De Backer Marianne 4

Accession 0001209191-23-022777

CIK 0001706431other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:53 PM ET

Size

7.2 KB

Accession

0001209191-23-022777

Insider Transaction Report

Form 4
Period: 2023-04-03
De Backer Marianne
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2023-04-03+576,452576,452 total
  • Award

    Stock Option (Right to Buy)

    2023-04-03+1,152,9041,152,904 total
    Exercise: $23.28Exp: 2033-04-02Common Stock (1,152,904 underlying)
Footnotes (2)
  • [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
  • [F2]25% of the shares subject to the stock option vest and become exercisable on April 3, 2024, and the remainder vest in 36 equal monthly installments thereafter.

Issuer

Vir Biotechnology, Inc.

CIK 0001706431

Entity typeother

Related Parties

1
  • filerCIK 0001797819

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:53 PM ET
Size
7.2 KB